Dimitry Nuyten SA's Insider Trades & SAST Disclosures
Dimitry Nuyten SA's most recent trade in Arcus Biosciences Inc was a trade of 7,856 Common Stock done at an average price of $16.1 . Disclosure was reported to the exchange on Dec. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Dimitry Nuyten SA.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcus Biosciences Inc | Dimitry SA Nuyten | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.08 per share. | 15 Dec 2024 | 7,856 | 87,518 (0%) | 0% | 16.1 | 126,324 | Common Stock |
| Arcus Biosciences Inc | Dimitry SA Nuyten | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.95 per share. | 15 Sep 2024 | 5,385 | 94,933 (0%) | 0% | 18.0 | 96,661 | Common Stock |
| Arcus Biosciences Inc | SA Dimitry Nuyten | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 113,700 | 113,700 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Nuyten SA Dimitry | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 28,000 | 99,195 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Dimitry Nuyten SA | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 18.09 per share. | 18 Dec 2023 | 1,540 | 71,195 (0%) | 0% | 18.1 | 27,859 | Common Stock |
| Arcus Biosciences Inc | Dimitry SA Nuyten | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 17.74 per share. | 18 Dec 2023 | 1,507 | 72,735 (0%) | 0% | 17.7 | 26,734 | Common Stock |
| Arcus Biosciences Inc | Dimitry SA Nuyten | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 20.40 per share. | 18 Sep 2023 | 3,708 | 73,591 (0%) | 0% | 20.4 | 75,643 | Common Stock |
| Arcus Biosciences Inc | Dimitry SA Nuyten | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 138,200 | 138,200 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Dimitry SA Nuyten | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 34,000 | 76,500 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Dimitry SA Nuyten | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Dimitry SA Nuyten | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 42,500 | 42,500 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges